- Home
- MATV vs MRVI Comparison
MATV vs MRVI Comparison
Compare MATV & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MATV | MRVI |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.1M | 559.0M |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MATV | MRVI |
|---|---|---|
| Price | $8.81 | $4.82 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 360.9K | ★ 2.6M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.24% | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $185,743,000.00 |
| Revenue This Year | $2.97 | $12.54 |
| Revenue Next Year | $4.20 | $7.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.03 | $1.99 |
| 52 Week High | $15.48 | $5.00 |
Technical Indicators
Market Signals| Indicator | MATV | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 47.90 | 68.22 |
| Support Level | $8.06 | $3.27 |
| Resistance Level | $8.95 | $5.00 |
| Average True Range (ATR) | 0.42 | 0.25 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 62.18 | 81.91 |
Price Performance
Historical ComparisonAbout MATV Mativ Holdings Inc.
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments, namely Filtration & advanced Materials, focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging, and healthcare solutions.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.